Pivanex
Pivanex (Pivalyloxymethyl butyrate) is an orally bioavailable histone deacetylase (HDAC) inhibitor with demonstrated antimetastatic and antiangiogenic properties. Research indicates it downregulates Bcr-Abl protein levels and induces apoptosis, showing activity in both in vitro cancer cell studies and in vivo animal models of leukemia and solid tumors.
Product Specifications
CAS Number
122110-53-6
Product Name Alternative
K562, myelogenous, muscular, inhibit, lung, NSCLC, lymphoblastic, leukemia, Inhibitor, HDAC, Histone deacetylases, ALL, Acute, Bcr-Abl, BcrAbl, cancer, Apoptosis, AN 9, AN9, AN-9, atrophy, CML, Chronic, spinal, Pivanex, Pivalyloxymethyl butyrate, Pivalyloxymethyl Butyrate
Field of Research
Cardiovascular Research, Cell Biology, Epigenetics & Chromatin, Molecular Biology, Signal Transduction
Purity
≥98% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (19.78 mM) ; DMSO:100 mg/mL (494.44 mM)
Smiles
CCCC (=O) OCOC (=O) C (C) (C) C
Molecular Formula
C10H18O4
Molecular Weight
202.25
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K4931806 1.0 µg DNA
Nol8 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1)
Sign In for Pricing
View Details 
